Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus impairs endothelial function, which can be considered as the hallmark in the development of cardiovascular diseases. Hyperglycemia, hyperinsulinemia, and hyperlipidemia are believed to contribute to endothelial dysfunction. In the present study, we investigated the possible links among these plasma metabolic markers and endothelial function in a mouse model during the development of type 2 diabetes. C57BL/6J-Lep ob/ob mice at 8, 12, and 16 weeks were used to study endothelial function during the establishment of type 2 diabetes. Endothelial function was accessed in vitro in the thoracic aorta by measuring acetylcholine (ACh)-stimulated vasodilatation. Blood plasma was obtained for the measurements of glucose, insulin, triglycerides, and cholesterol levels. Correlation and multiple regression analysis revealed strong negative associations between the ACh responsiveness and the plasma levels of glucose, insulin, and lipid profiles at the age of 8 weeks. Associations were observed at neither older age nor in C57BL/6J mice. In conclusion, the increase in plasma levels of glucose, insulin, and lipids is associated with the impairment of the endothelial function during the early stage of the development of type 2 diabetes. The loss of correlation at an older age suggests multifactorial regulation of endothelial function and cardiovascular complications at later stages of the disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T2D is characterised by pancreatic beta-cell dysfunction, increased pancreatic alpha-cell function, and peripheral tissue insulin resistance.”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [31]
Citations
Cites
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277 · cited 1×
“2003) enhance oxidative stress owing to increased mitochondrial uncoupling (Nishikawa et al. 2000), NADPH activation (Guzik et al.”
BackgroundOxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Nofer, J.-R., van der Giet, M., Tölle, M., Wolinska, I., von Wnuck Lipinski, K., Baba, H. A., Tietge, U. J., Gödecke, A., Ishii, I., Kleuser, B., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18004 · Cited by 698
Tripathy, D., Mohanty, P., Dhindsa, S., Syed, T., Ghanim, H., Aljada, A., & Dandona, P. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2882 · Cited by 660 · cited 2×
“Increased levels of free fatty acids directly decreased flowmediated vasodilation (Tripathy et al. 2003).”
BackgroundGlucose Challenge Stimulates Reactive Oxygen Species (ROS) Generation by Leucocytes
Mohanty, P. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2970 · Cited by 622 · cited 1×
“In humans, increased levels of glucose (Mohanty et al. 2000) and free fatty acids (Tripathy et al.”
BackgroundHDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3
Nofer, J., van der Giet, M., Tölle, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418004 · Cited by 607
Platelet Activation in Obese Women: Role of Inflammation and Oxidant Stress
Davì, G., Guagnano, M. T., Ciabattoni, G., Basili, S., Falco, A., Marinopiccoli, M., Nutini, M., Sensi, S., & Patrono, C. (2002) · JAMA · doi:10.1001/jama.288.16.2008 · Cited by 541
Regulation of Endothelial Nitric Oxide Synthase by Tetrahydrobiopterin in Vascular Disease
Alp, N. J., & Channon, K. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000110785.96039.f6 · Cited by 531 · cited 1×
“2002), and eNOS uncoupling (Alp and Channon 2004), and hyperglycemia leads to mitochondrial dysfunction and activation of stress-activated signaling pathways (Evans et al.”
BackgroundMechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes
Rask-Madsen, C., & King, G. L. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0366 · Cited by 484 · cited 4×
“Dysfunction of the endothelium is a universal feature of cardiovascular diseases and is consistently demonstrated in vivo and in vitro in diabetes (Okon et al. 2005; Thorand et al. 2006; Rask-Madsen and King 2007).”
BackgroundInfluentialFederici, M., Menghini, R., Mauriello, A., Hribal, M. L., Ferrelli, F., Lauro, D., Sbraccia, P., Spagnoli, L. G., Sesti, G., & Lauro, R. (2002) · Circulation · doi:10.1161/01.cir.0000023043.02648.51 · Cited by 373
Dandona, P., Mohanty, P., Ghanim, H., Aljada, A., Browne, R., Hamouda, W., Prabhala, A., Afzal, A., & Garg, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7150 · Cited by 370
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19992 · Cited by 309 · cited 1×
“Insulin resistance could result in increased lipid levels in blood (Altomonte et al. 2004).”
BackgroundFoxo1 mediates insulin action on apoC-III and triglyceride metabolism
Altomonte, J., Lin, C., Harbaran, S., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419992 · Cited by 260
A simple measure of insulin resistance
Duncan, M. H., Singh, B. M., Wise, P. H., Carter, G., & Alaghband-Zadeh, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92143-5 · Cited by 252
High-Density Lipoproteins and Endothelial Function
O’Connell, B. J., & Genest, J. (2001) · Circulation · doi:10.1161/hc3901.096667 · Cited by 217 · cited 2×
“HDL is known to be protective for endothelial function (O’Connell and Genest 2001).”
BackgroundDandona, P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.355 · Cited by 170
The Mechanism of Collagen Cross-Linking in Diabetes: A Puzzle Nearing Resolution
Monnier, V. M., Glomb, M., Elgawish, A., & Sell, D. R. (1996) · Diabetes · doi:10.2337/diab.45.3.s67 · Cited by 164 · cited 1×
“2002) and antioxidant enzyme (Zhao and Shen 2005) inactivation and extracellular matrix modifications (Monnier et al. 1996; Bishara et al. 2002).”
BackgroundThorand, B., Baumert, J., Chambless, L., Meisinger, C., Kolb, H., Döring, A., Löwel, H., & Koenig, W. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000198392.05307.aa · Cited by 156 · cited 2×
“Dysfunction of the endothelium is a universal feature of cardiovascular diseases and is consistently demonstrated in vivo and in vitro in diabetes (Okon et al. 2005; Thorand et al. 2006; Rask-Madsen and King 2007).”
BackgroundZmijewski, J. W., Moellering, D. R., Goffe, C. L., Landar, A., Ramachandran, A., & Darley-Usmar, V. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00015.2005 · Cited by 148 · cited 1×
“One is through the deterioration of oxidative stress owing to the stimulation of endothelial reactive oxygen species (ROS) by oxidized LDL (Zmijewski et al. 2005), which leads to an inflammatory response (Robbesyn et al.”
BackgroundCompromised Arterial Function in Human Type 2 Diabetic Patients
Okon, E. B., Chung, A. W. Y., Rauniyar, P., Padilla, E., Tejerina, T., McManus, B. M., Luo, H., & van Breemen, C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2415 · Cited by 141 · cited 1×
“Dysfunction of the endothelium is a universal feature of cardiovascular diseases and is consistently demonstrated in vivo and in vitro in diabetes (Okon et al. 2005; Thorand et al. 2006; Rask-Madsen and King 2007).”
BackgroundSelf-citationHurst, R. T., & Lee, R. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00010 · Cited by 139
Attenuation of Renal Injury in db/db Mice Overexpressing Superoxide Dismutase
DeRubertis, F. R., Craven, P. A., Melhem, M. F., & Salah, E. M. (2004) · Diabetes · doi:10.2337/diabetes.53.3.762 · Cited by 129
Silver, D. L., Jiang, X.-C., & Tall, A. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4140 · Cited by 125
Fang, Y., Mohler, E. R., Hsieh, E., Osman, H., Hashemi, S. M., Davies, P. F., Rothblat, G. H., Wilensky, R. L., & Levitan, I. (2006) · Circulation Research · doi:10.1161/01.res.0000218776.87842.43 · Cited by 106
Augmented Contractile Response of Vascular Smooth Muscle in a Diabetic Mouse Model
Okon, E. B., Szado, T., Laher, I., McManus, B., & van Breemen, C. (2003) · Journal of Vascular Research · doi:10.1159/000075238 · Cited by 106 · cited 7×
“Diabetes is known to modify endothelial function (Dandona et al. 2004; Thorand et al. 2006; Okon et al. 2003), causing a shift from the production of relaxing factors to the increased production of vasoconstrictors (Rask-Madsen and King 2007).”
BackgroundMethodSelf-citationRobbesyn, F., Garcia, V., Auge, N., Vieira, O., Frisach, M., Salvayre, R., & Negre‐Salvayre, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0240fje · Cited by 104 · cited 2×
“HDL improves endothelial function (O’Connell and Genest 2001) counteracting the effect of oxidized LDL (Robbesyn et al. 2003), as well as activating intracellular Akt signaling cascade (Schmidt et al.”
BackgroundCeolotto, G., Bevilacqua, M., Papparella, I., Baritono, E., Franco, L., Corvaja, C., Mazzoni, M., Semplicini, A., & Avogaro, A. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1344 · Cited by 87
Functional modulation of antioxidant enzymes in vascular endothelial cells by glycated LDL
Zhao, R., & Shen, G. X. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.013 · Cited by 79 · cited 1×
“2002) and antioxidant enzyme (Zhao and Shen 2005) inactivation and extracellular matrix modifications (Monnier et al.”
BackgroundBaeza, N., Moriscot, C., Renaud, W., Okamoto, H., Figarella, C., & Vialettes, B. (1996) · Diabetes · doi:10.2337/diab.45.1.67 · Cited by 63
A novel advanced glycation index and its association with diabetes and microangiopathy
Rangasamy, S., Balasubramanyam, M., Rema, M., Premanand, C., & Mohan, V. (2005) · Metabolism · doi:10.1016/j.metabol.2005.02.017 · Cited by 59 · cited 1×
“The levels of advanced glycated products also correlate with cholesterol and triglycerides in diabetic patients and with microangiopathy in this cohort (Sampathkumar et al. 2005).”
BackgroundNie, H., Wu, J., Zhang, M., Xu, J., & Zou, M. (2006) · Diabetes · doi:10.2337/db06-0505 · Cited by 51 · cited 2×
“2006), which in particular result in eNOS (Nie et al. 2006; Federici et al. 2002) and antioxidant enzyme (Zhao and Shen 2005) inactivation and extracellular matrix modifications (Monnier et al.”
BackgroundPretreatment with simvastatin reduces myocardial no‐reflow by opening mitochondrial KATP channel
Zhao, J., Yang, Y., Cui, C., Sj, Y., & Rl, G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706862 · Cited by 47 · cited 1×
“2006) and mitochondrial potassium channels (Zhao et al. 2006).”
Inhibition of insulin signaling by oxidized low density lipoprotein
Mazière, C., Morlière, P., Santus, R. C., Marcheux, V., Louandre, C., Conte, M.-A., & Mazière, J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.02.006 · Cited by 45
Fegan, P. G., Shore, A. C., Mawson, D., Tooke, J. E., & MacLeod, K. M. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01719.x · Cited by 44
Endothelial dysfunction and hypertension in diabetes mellitus
Dandona, P., Chaudhuri, A., & Aljada, A. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.04.006 · Cited by 42
Schmidt, A., Geigenmüller, S., Völker, W., & Buddecke, E. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-005-0582-z · Cited by 41
Miike, T., Kunishiro, K., Kanda, M., Azukizawa, S., Kurahashi, K., & Shirahase, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0261-3 · Cited by 38
Leckström, A., Lundquist, I., Ma, Z., & Westermark, P. (1999) · Pancreas · doi:10.1097/00006676-199904000-00008 · Cited by 37
Matrix protein glycation impairs agonist‐induced intracellular Ca2+ signaling in endothelial cells
Bishara, N. B., Dunlop, M., Murphy, T. V., Darby, I. A., Rajanayagam, M. A. S., & Hill, M. A. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10153 · Cited by 33 · cited 1×
“2002) and antioxidant enzyme (Zhao and Shen 2005) inactivation and extracellular matrix modifications (Monnier et al. 1996; Bishara et al. 2002).”
BackgroundZhang, Y., Hong, J., Zhan, W., Li, X., Gu, W., Yang, Y., Xu, M., & Ning, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02440.x · Cited by 32
Paniagua, J. A., López‐Miranda, J., Pérez‐Martínez, P., Marín, C., Vida, J. M. G., Fuentes, F., de la Puebla, R. Á. F., & Pérez‐Jiménez, F. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01703.x · Cited by 26
Dell’Omo, G., Penno, G., Prato, S. D., & Pedrinelli, R. (2005) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/107424840501000406 · Cited by 17
Relation of Basal Coronary Nitric Oxide Activity to the Burden of Atherosclerosis
Anderson, T. J., Worthley, M. I., Goodhart, D. M., & Curtis, M. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.044 · Cited by 7 · cited 1×
“Since endothelium-derived nitric oxide is an important vasodilatator and an anti-atherogenic factor, endothelial dysfunction would disrupt control of vasodilatation, tissue perfusion, hemostasis, and thrombosis and lead to atherosclerosis and coronary artery disease (Anderson et al. 2005).”
Background
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Metabolic Syndrome Is Associated with Oxidative Stress and Proinflammatory State
Monserrat-Mesquida, M., Quetglas-Llabrés, M., Capó, X., Bouzas, C., Mateos, D., Pons, A., Tur, J. A., & Sureda, A. (2020) · Antioxidants · doi:10.3390/antiox9030236 · Cited by 234
Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches
Mohamed, S. M., Shalaby, M. A., El-Shiekh, R. A., El-Banna, H. A., Emam, S. R., & Bakr, A. F. (2023) · Food Chemistry Advances · doi:10.1016/j.focha.2023.100335 · Cited by 236
Interrelationship between diabetes and periodontitis: Role of hyperlipidemia
Zhou, X., Zhang, W., Liu, X., Zhang, W., & Li, Y. (2014) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2014.11.008 · Cited by 162
Guo, W., Chen, M., Pan, W., Zhang, Q., Xu, J., Lin, Y., Lü, L., Liu, B., Bai, W., Zhang, Y., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.206 · Cited by 98
Metadata
- Authors
- Okon, E. B., Chung, A. W. Y., Zhang, H., Laher, I., & van Breemen, C.
- Affiliations
- University of British Columbia (CA)
- James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul’s Hospital, 1081 Burrard Street, University of British Columbia, Vancouver, BC V6Z 1Y6, Canada
- Venue
- Canadian Journal of Physiology and Pharmacology
- Publisher
- Canadian Science Publishing
- Published
- 2007-05
- Volume
- 85
- Issue
- 5
- Pages
- 562-567
- ISSN
- 0008-4212 (ISSN-L)
- 1205-7541
- OpenAlex
- W2030698401
- Cited by
- 50
- References
- 42
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 3 · 2014: 3 · 2013: 1
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Canadian Journal of Physiology and Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Association for Institutional Research
- Heart and Stroke Foundation of British Columbia and Yukon
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- endothelial dysfunction, type 2 diabetes, hyperglycemia, hyperlipidemia, hyperinsulinemia, thoracic aorta, plasma glucose, plasma insulin, plasma lipids, cardiovascular complications
- MeSH terms
- Acetylcholine, Age Factors, Animals, Aorta, Blood Glucose, Cholesterol, Diabetes Mellitus, Type 2, Endothelium, Vascular, Female, Hyperglycemia, Hyperlipidemias, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Regression Analysis, Triglycerides, Vasodilation, Vasodilator Agents, Mice, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.